9 drug(s) with this reaction
38,806 total reports
Peripheral Swelling has been reported as an adverse reaction across 9 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 38,806 adverse event reports mention peripheral swelling in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with peripheral swelling, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have peripheral swelling listed in their FDA adverse event reports, sorted by report count:
In addition to peripheral swelling, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
9 drug(s) manufactured by Abbvie Inc have peripheral swelling listed in their FDA adverse event reports: Humira, ADALIMUMAB, LEVOTHYROXINE SODIUM, UPADACITINIB, RISANKIZUMAB-RZAA, and others.
There are a combined 38,806 reports of peripheral swelling across 9 Abbvie Inc drug(s) in the FDA adverse event database.